Aseptic osteonecrosis in children and adolescents treated for hemato-oncologic diseases: A 13-year longitudinal observational study

Journal of Pediatric Hematology/Oncology

Volumn 27, Issue 5, 2005, Pages 259-263

  Lackner, Herwig ^a   Benesch, Martin ^a   Moser, Andrea ^a   Smolle Jüttner, Freya ^a   Linhart, Wolfgang ^a   Raith, Johann ^a   Urban, Christian ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Aseptic osteonecrosis; Children; Hematological malignancies; Therapy

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; ILOPROST; PAMIDRONIC ACID; PREDNISONE; PROSTACYCLIN DERIVATIVE;

ADOLESCENT; ADULT; ARTHROTOMY; ARTICLE; ASEPTIC NECROSIS; BLOOD DYSCRASIA; CHILDHOOD CANCER; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; HYPERBARISM; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; QUALITY OF LIFE; RETROSPECTIVE STUDY; RISK FACTOR;

ADOLESCENT; CHILD; FEMALE; FOLLOW-UP STUDIES; HEMATOLOGIC NEOPLASMS; HUMANS; LONGITUDINAL STUDIES; MALE; NEOPLASMS; OSTEONECROSIS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 18944379250     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mph.0000163215.37147.13     Document Type: Article

References (26)

1. Prindull G, Weigel W, Jentsch E, et al. Aseptic osteonecrosis in children treated for acute lymphoblastic leukemia and aplastic anemia. Eur J Pediatr. 1982;139:48-51.
2. Felix C, Blatt J, Goodman MA, et al. Avascular necrosis of bone following combination chemotherapy for acute lymphocytic leukemia. Med Pediatr Oncol. 1985;13:269-272.
3. Ishii E, Yoshida N, Miyazaki S. Avascular necrosis of bone in neuroblastoma treated with combination chemotherapy. Eur J Pediatr. 1984;143:152-153.
4. Bömelburg T, von Lengerke HJ, Ritter J. Aseptic osteonecroses in the treatment of childhood acute leukaemias. Eur J Pediatr. 1989;149: 20-23.
5. Murphy RG, Greenberg ML. Osteonecrosis in pediatric patients with acute lymphoblastic leukemia. Cancer. 1990;65:1717-1721.
6. Strauss AJ, Su JT, Dalton VM, et al. Bony morbidity in children treated for acute lymphoblastic leukemia. J Clin Oncol. 2001;19:3066-3072.
7. Levien MG. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group. Clin Pediatr (Phila). 2002;41:63-64.
8. Mattano LA Jr, Sather HN, Trigg ME, et al. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group. J Clin Oncol. 2000;18:3262-3272.
9. Ojala AE, Lanning FP, Pääkkö E, et al. Osteonecrosis in children treated for acute lymphoblastic leukemia: a magnetic resonance imaging study after treatment. Med Pediatr Oncol. 1997;29:260-265.
10. Bojko P, Hilger RA, Ruehm SG, et al. Femoral head necrosis in three patients with relapsed ovarian cancer receiving high-dose chemotherapy followed by autologous peripheral stem cell transplantation. Bone Marrow Transplant. 2003;31:487-491.
11. Mascarin M, Giavitto M, Zanazzo GA, et al. Avascular necrosis of bone in children undergoing allogeneic bone marrow transplantation. Cancer. 1991; 68:655-659.
12. Bernbeck B, Krauth KA, Scherer A, et al. Aseptic osteonecrosis in a child with nephroblastoma healed by hyperbaric oxygen therapy. Med Pediatr Oncol. 2002;39:47-48.
13. Schrappe M, Reiter A, Ludwig WD, et al. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group. Blood. 2000;95:3310-3322.
14. Reiter A, Schrappe M, Tiemann M, et al. Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90. Blood. 1999;94:3294-3306.
15. Dörffel W, Lüders H, Rühl U, et al. Preliminary results of the multicenter trial GPOH-HD 95 for the treatment of Hodgkin's disease in children and adolescents: analysis and outlook. Klin Pädiatr. 2003;215:139-145.
16. Attarbaschi A, Mann G, Dworzak M, et al. Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria: therapy results between 1986 and 2000. Wien Klin Wochenschr. 2002;114:978-986.
17. Reinhardt D, Langebrake C, Creutzig U, et al. Minimal residual disease in acute myeloid leukemia in children: standardization and evaluation of immunophenotyping in the AML-BFM-98 study. Klin Pädiatr. 2002;214: 179-187.
18. Lackner H, Benesch M, Schagerl S, et al. Prospective evaluation of late effects after childhood cancer therapy with a follow-up over 9 years. Eur J Pediatr. 2000;159:750-758.
19. Scherer A, Engelbrecht V, Krauth KA, et al. MRI follow-up study of aseptic osteonecrosis (AON) in children treated with chemotherapy for malignant diseases. Klin Pädiatr. 2001;213:56-62.
20. Marx RE. Clinical applications of hyperbaric oxygen. In: Kindwall EP, ed. Hyperbaric Medicine Practice. Arizona: Best Publishing, 1995:464-468.
21. Chavez JA, Adkinson CD. Adjunctive hyperbaric oxygen in irradiated patients requiring dental extractions: outcomes and complications. J Oral Maxillofac Surg. 2001;59:518-522.
22. Aigner N, Petje G, Steinboeck G, et al. Treatment of bone marrow oedema of the talus with the prostacyclin analogue iloprost. An MRI-controlled investigation of a new method. J Bone Joint Surg [Br]. 2001;83:855-858.
23. Aigner N, Petje G, Schneider W, et al. Juvenile bone-marrow oedema of the acetabulum treated by iloprost. J Bone Joint Surg [Br]. 2002;84:1050-1052.
24. Varenna M, Zucchi F, Binelli L, et al. Intravenous pamidronate in the treatment of transient osteoporosis of the hip. Bone. 2002;31:96-101.
25. Pritchett JW. Statin therapy decreases the risk of osteonecrosis in patients receiving steroids. Clin Orthop. 2001;386:173-178.
26. Glueck CJ, McMahon RE, Bouquot JE, et al. A preliminary pilot study of treatment of thrombophilia and hypofibrinolysis and amelioration of the pain of osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85:64-73.